CXS
Click for more information
0.00% 70.0¢ chemgenex pharmaceuticals ltd

rbs revised report on cxs , page-10

  1. diersel
    442 Posts.
    lightbulb Created with Sketch. 7
    clock Created with Sketch.
    21/05/10
    10:03
    Post #: 6720236
    It is estimated CXS will have around $13 million in cash at the end of June.

    Capital raising will all depend on how long things play out with the FDA re: diagnostic.

    The company should have clear guidance once they meet with the FDA in June - looking forward to this meeting being announced very soon.

    CXS Price at posting: 32.5¢ Sentiment: LT Buy Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

RLT South Africa-based Renergen brings liquid helium facility online
right-arrow Created with Sketch.
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
right-arrow Created with Sketch.
NEWS Dale Gillham's weekly wrap: picking resilient stocks in a volatile global market
right-arrow Created with Sketch.
NEWS Bitcoin: Current State of Play & Where to Next | Swyftx
right-arrow Created with Sketch.
QBE QBE records share price plunge despite doubling profits in the first half of 2024
right-arrow Created with Sketch.
TG6 TG Metals reports high grade lithium hits approaching 3% at Jaegermeister
right-arrow Created with Sketch.
watchlist Created with Sketch. Add CXS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.